Susquehanna International Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Susquehanna International Group’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,300	Closed	-$17K	–	14465
2022 Q2	$17K	Sell	10,300 -8,500	-45%	-$17.7K	﹤0.01%	12410
2022 Q1	$55K	Sell	18,800 -37,900	-67%	-$133K	﹤0.01%	12274
2021 Q4	$271K	Buy	56,700 +8,500	+18%	+$54.9K	﹤0.01%	10728
2021 Q3	$365K	Sell	48,200 -98,500	-67%	-$630K	﹤0.01%	10133
2021 Q2	$1.09M	Sell	146,700 -50,900	-26%	-$392K	﹤0.01%	7520
2021 Q1	$1.54M	Buy	197,600 +60,900	+45%	+$609K	﹤0.01%	6573
2020 Q4	$1.26M	Buy	+136,700	New	+$1.19M	﹤0.01%	6138

Susquehanna International Group's SURF Position: Q3 2023 in Review

Susquehanna International Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 52,149 shares — an estimated $45.3K sold.

Susquehanna International Group first reported a position in SURF in Q4 2020 and held it in 11 quarters. The position peaked at $3.19M in Q1 2021. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Susquehanna International Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Susquehanna International Group sold 52,149 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $45.3K.
Susquehanna International Group first reported a position in Surface Oncology, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Susquehanna International Group's Surface Oncology, Inc. Common Stock position peaked at $3.19M in Q1 2021.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.